8-K
filed June 2, 2023, 7:59 PM ET
ticker XENE
CIK 0001582313
other
confidence high
sentiment neutral
materiality 0.15
Xenon Pharmaceuticals announces results of 2023 annual meeting; all proposals approved
Xenon Pharmaceuticals Inc.
- All 8 director nominees elected; highest vote count 50.7M (Svoronos, Gannon), lowest 48.5M (Machado).
- Say-on-pay advisory vote approved: 44.2M for, 6.7M against, 3.3K abstain; 1.9M broker non-votes.
- KPMG appointed as auditor with 51.5M votes for, 1.3M withheld.
- Auditor remuneration authority approved: 50.7M for, 284K against, 2.8K abstain; 1.8M broker non-votes.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Xenon Pharmaceuticals Inc. shareholders approved Remuneration of Auditor at the 2023-06-01 meeting.
- Outcome
- passed
- Meeting
- 2023-06-01
Exact text from the filing
The authority of the audit committee of the Board to set the remuneration of the auditor for the ensuing year was approved as follows: For Against Abstain Broker Non-Votes 50,683,345 284,460 2,832 1,827,721
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Xenon Pharmaceuticals Inc. shareholders approved Election of Directors at the 2023-06-01 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-01
Exact text from the filing
The following nominees were elected as directors to serve until the 2024 annual meeting of shareholders or until their respective successors are duly elected and qualified: For Against Broker Non-Votes Simon Pimstone 49,766,312 1,105,033 1,927,013 Dawn Svoronos 50,657,151 214,194 1,927,013 Mohammad Azab 49,442,996 1,428,349 1,927,013 Steven Gannon 50,683,492 187,853 1,927,013 Elizabeth Garofalo 50,657,402 213,943 1,927,013 Patrick Machado 48,515,986 2,355,359 1,927,013 Ian Mortimer 50,663,448 207,897 1,927,013 Gary Patou 48,629,611 2,241,734 1,927,013
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Xenon Pharmaceuticals Inc. shareholders approved Advisory Vote on Compensation of Named Executive Officers (Say-on-Pay) at the 2023-06-01 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-01
Exact text from the filing
The compensation of the Company’s named executive officers, on an advisory basis, was approved as follows: For Against Abstain Broker Non-Votes 44,167,661 6,700,364 3,320 1,927,013
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Xenon Pharmaceuticals Inc. shareholders approved Appointment of Auditor at the 2023-06-01 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-01
Exact text from the filing
The appointment of KPMG LLP as the Company’s independent registered public accounting firm for the ensuing year was approved as follows: For Withheld Broker Non-Votes 51,532,487 1,265,871 0
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.